Farallon Capital Management Comments on Election of All Three of Its Nominees to Exelixis' BoardBusiness Wire • 05/31/23
Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the DipThe Motley Fool • 05/13/23
Compared to Estimates, Exelixis (EXEL) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 05/10/23
Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate UpdateBusiness Wire • 05/09/23
Farallon Capital Management Comments on Successful Campaign for Change at ExelixisBusiness Wire • 05/08/23
Exelixis to Present at the BofA Securities 2023 Healthcare Conference on May 10, 2023Business Wire • 05/03/23
Farallon Capital Urges Exelixis Shareholders to Support Change by Electing Its Three Highly Qualified Director CandidatesBusiness Wire • 05/03/23
Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023Business Wire • 04/25/23
Wall Street Analysts See a 36.54% Upside in Exelixis (EXEL): Can the Stock Really Move This High?Zacks Investment Research • 04/25/23
Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the DipThe Motley Fool • 04/22/23
Farallon Issues Letter to Exelixis Board of Directors Outlining Case for ChangeBusiness Wire • 04/05/23